{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-040955","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2024-10-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.387092+00:00","generated_at":"2026-05-30T15:44:46.350819+00:00","sec_items":["3.03","5.03","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Mangoceuticals announces 1-for-15 reverse stock split to meet Nasdaq $1 bid price","bullets":["Reverse stock split at 1:15 ratio effective October 16, 2024 at 12:01 a.m. ET.","Outstanding shares reduced from ~35.5M to ~2.4M (subject to fractional rounding).","Split aimed at regaining Nasdaq minimum $1.00 bid price; compliance deadline Oct 28, 2024.","Trading symbol MGRX unchanged; proportional adjustments made to options and warrants.","Authority granted by stockholders in March 2024; final ratio set by Board on Oct 7, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-040955","json":"https://secwatch.observer/filing/0001493152-24-040955.json","markdown":"https://secwatch.observer/filing/0001493152-24-040955.md","text":"https://secwatch.observer/filing/0001493152-24-040955.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224040955/0001493152-24-040955-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315224040955/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T15:44:46.350819+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}